• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

舍他康唑/羟丙基-β-环糊精络合:等温滴定量热法和溶解度研究方法

Sertaconazole/hydroxypropyl-beta-cyclodextrin complexation: isothermal titration calorimetry and solubility approaches.

作者信息

Rodriguez-Perez Ana I, Rodriguez-Tenreiro Carmen, Alvarez-Lorenzo Carmen, Taboada Pablo, Concheiro Angel, Torres-Labandeira Juan J

机构信息

Departamento de Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Universidad de Santiago de Compostela, Spain.

出版信息

J Pharm Sci. 2006 Aug;95(8):1751-62. doi: 10.1002/jps.20661.

DOI:10.1002/jps.20661
PMID:16795015
Abstract

Complexation of sertaconazole (SN) with hydroxypropyl-beta-cyclodextrin (HP-beta-CD) was characterized by phase-solubility diagram measurements and isothermal calorimetry (ITC) in aqueous medium, and by differential scanning calorimetry (DSC), Raman spectroscopy and X-ray diffractometry in solid state. The strongest interaction was observed at pH 1.2, at which two different 1:1 complexes can be formed depending on the hydrophobic ring of the drug involved in the process. At pH 5.8 and 7.4 the likelihood of 1:2 stoichiometry increases as a consequence of the simultaneous complexation of the nonprotonized imidazolyl and the dichlorophenyl groups. In the presence of 20% HP-beta-CD, SN solubility is enhanced by a factor of 116, 107, and 5 at pH 1.2, 5.8, and 7.4, respectively. Complexation enthalpy recorded by ITC showed the same tendency which confirms the practical interest of this technique for fast screening of the potential of CDs as drug solubilizers. Solubility and dissolution rate of the drug from compacts prepared with freeze-dried complexes were significantly greater than those obtained with SN powder or compacts made with physical blends.

摘要

在水介质中,通过相溶解度图测量和等温滴定量热法(ITC),以及在固态下通过差示扫描量热法(DSC)、拉曼光谱和X射线衍射法对舍他康唑(SN)与羟丙基-β-环糊精(HP-β-CD)的络合作用进行了表征。在pH 1.2时观察到最强的相互作用,此时根据参与该过程的药物疏水环可形成两种不同的1:1络合物。在pH 5.8和7.4时,由于未质子化的咪唑基和二氯苯基同时络合,1:2化学计量比的可能性增加。在20% HP-β-CD存在下,SN在pH 1.2、5.8和7.4时的溶解度分别提高了116倍、107倍和5倍。ITC记录的络合焓显示出相同的趋势,这证实了该技术对于快速筛选环糊精作为药物增溶剂潜力的实际意义。用冻干络合物制备的片剂中药物的溶解度和溶出速率显著高于用SN粉末或物理混合物制成的片剂。

相似文献

1
Sertaconazole/hydroxypropyl-beta-cyclodextrin complexation: isothermal titration calorimetry and solubility approaches.舍他康唑/羟丙基-β-环糊精络合:等温滴定量热法和溶解度研究方法
J Pharm Sci. 2006 Aug;95(8):1751-62. doi: 10.1002/jps.20661.
2
Effect of cyclodextrins on the solubility and antimycotic activity of sertaconazole: experimental and computational studies.环糊精对舍他康唑溶解度和抗真菌活性的影响:实验与计算研究
J Pharm Sci. 2002 Nov;91(11):2408-15. doi: 10.1002/jps.10237.
3
Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.他达拉非与天然及化学修饰的β-环糊精的包合物。I:制备及体外评价
Eur J Pharm Biopharm. 2008 Nov;70(3):819-27. doi: 10.1016/j.ejpb.2008.06.024. Epub 2008 Jul 4.
4
Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.采用超临界抗溶剂(SAS)法制备辛伐他汀/羟丙基-β-环糊精包合物及其表征
Eur J Pharm Biopharm. 2007 Jun;66(3):413-21. doi: 10.1016/j.ejpb.2006.11.013. Epub 2006 Nov 29.
5
Inclusion complexes of fluorofenidone with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.氟苯尼考与β-环糊精和羟丙基-β-环糊精的包合物。
Drug Dev Ind Pharm. 2009 Jul;35(7):808-13. doi: 10.1080/03639040802612944.
6
Effect of pH on the complexation of kaempferol-4'-glucoside with three β-cyclodextrin derivatives: isothermal titration calorimetry and spectroscopy study.pH对山奈酚-4'-葡萄糖苷与三种β-环糊精衍生物络合作用的影响:等温滴定量热法和光谱研究
J Agric Food Chem. 2014 Jan 8;62(1):244-50. doi: 10.1021/jf404320w. Epub 2013 Dec 19.
7
Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin.瑞格列奈与羟丙基-β-环糊精制剂的制备、表征及体内评价
Int J Pharm. 2014 Dec 30;477(1-2):159-66. doi: 10.1016/j.ijpharm.2014.10.038. Epub 2014 Oct 16.
8
Dramatic improvement of the solubility of pseudolaric acid B by cyclodextrin complexation: preparation, characterization and validation.环糊精包合作用对土槿皮酸B溶解度的显著改善:制备、表征及验证
Int J Pharm. 2015 Feb 20;479(2):349-56. doi: 10.1016/j.ijpharm.2015.01.005. Epub 2015 Jan 6.
9
Inclusion complex of trimethoprim with beta-cyclodextrin.甲氧苄啶与β-环糊精的包合物
J Pharm Biomed Anal. 2005 Sep 15;39(3-4):824-9. doi: 10.1016/j.jpba.2005.05.011.
10
Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.黄芩苷与羟丙基-β-环糊精制剂的制备、表征及体内评价
Int J Pharm. 2006 Apr 7;312(1-2):137-43. doi: 10.1016/j.ijpharm.2006.01.011. Epub 2006 Feb 3.

引用本文的文献

1
Ionic resorcinarenes as drug solubilization agents in water.离子型间苯二酚芳烃作为水中的药物增溶剂。
RSC Adv. 2024 Oct 28;14(46):34228-34238. doi: 10.1039/d4ra06682k. eCollection 2024 Oct 23.
2
Theoretical Investigations on Free Energy of Binding Cilostazol with Different Cyclodextrins as Complex for Selective PDE3 Inhibition.西洛他唑与不同环糊精结合的结合自由能的理论研究:作为选择性 PDE3 抑制的复合物。
Molecules. 2024 Aug 12;29(16):3824. doi: 10.3390/molecules29163824.
3
Biomimetic Systems Involving Macrophages and Their Potential for Targeted Drug Delivery.
涉及巨噬细胞的仿生系统及其在靶向药物递送方面的潜力。
Biomimetics (Basel). 2023 Nov 12;8(7):543. doi: 10.3390/biomimetics8070543.
4
Clotrimazole-cyclodextrin based approach for the management and treatment of Candidiasis - A formulation and chemistry-based evaluation.基于克霉唑-环糊精的念珠菌病管理与治疗方法——基于制剂和化学的评估
Pharm Dev Technol. 2016 Aug;21(5):619-29. doi: 10.3109/10837450.2015.1041041. Epub 2015 Apr 29.